The Pennant Group Issues Amended Financial Statements for Acquired Amedisys Subsidiaries

Reuters12-17
<a href="https://laohu8.com/S/PNTG">The Pennant</a> Group Issues Amended Financial Statements for Acquired Amedisys Subsidiaries

The Pennant Group Inc. has issued an amendment to its current report, providing audited abbreviated financial statements for the acquired Amedisys subsidiaries as of and for the year ended December 31, 2024. The amendment includes statements of revenue and direct expenses, assets acquired, and liabilities assumed, along with related notes, to comply with SEC requirements.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Pennant Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001766400-25-000147), on December 17, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment